Overview of Dr. Azadi
HonorHealth Cancer Care gives you access to an elite team of experts across the Valley. The physicians who we collaborate with are nationally and internationally recognized.
Dr. Azadi specializes in Neuro Oncology with a focus on brain and skull base tumors. His expertise includes the diagnosis and treatment of brain, head and neck tumors. Dr. Azadi's research interests include precision medicine and immunotherapy in primary and secondary brain tumors.
Dr. Azadi offers a variety of treatment options for conditions including acoustic neuroma, astrocytoma, benign nervous system tumors, brain cancer, brain metastasis, brain tumors, chordoma, choroid plexus papilloma, ependymoma, glioblastoma, glioma, leptomeningeal carcinomatosis (LC), meningioma, neurofibroma, neurofibromatosis, oligodendroglioma, peripheral nerve tumors, pituitary tumors, secondary brain tumors and spinal cord tumors.
Dr. Azadi’s priority is to provide his patients with personalized, compassionate care using the most up-to-date treatment options. He listens to his patients, and collaboratively they choose the best treatment option for their cancer. He strives to deliver the most effective cancer management and treatment strategies, while providing encouragement and support for his patients.
Office
2910 N 3rd Ave
# 470
Phoenix, AZ 85013Fax+1 602-406-2931
Education & Training
- Barrow Neurological Institute at St Joseph's Hospital and Medical CenterFellowship, Neuro-Oncology, 2018 - 2019
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2011 - 2014
- Shahid Beheshti University of Medical SciencesClass of 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2019 - 2026
- KY State Medical License 2014 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsRethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemicKevin C J Yuen, Michael J. Mortensen, Amir Azadi, Ekokobe Fonkem, James W. Findling
Endocrinology, Diabetes & Metabolism. 2021-03-08 - 188 citationsPharmacokinetic consequences of pegylation.Mehrdad Hamidi, Amir Azadi, Pedram Rafiei
Drug Delivery. 2006-11-01 - 5 citationsMolecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields.Manjari Pandey, Joanne Xiu, Sandeep Mittal, Jia Zeng, Michelle Saul
Neuro-Oncology Advances. 2022-06-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: